go 6976 has been researched along with Leukemia, Myeloid in 2 studies
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human myelogenous leukemia K562 cells were induced to undergo megakaryocytic differentiation by long-term treatment with phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA)." | 1.34 | Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells. ( Chou, CC; Hsu, CY; Yung, BY, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grandage, VL | 1 |
| Everington, T | 1 |
| Linch, DC | 1 |
| Khwaja, A | 1 |
| Chou, CC | 1 |
| Yung, BY | 1 |
| Hsu, CY | 1 |
2 other studies available for go 6976 and Leukemia, Myeloid
| Article | Year |
|---|---|
Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells.
Topics: Acute Disease; Carbazoles; Cell Division; Cell Line, Tumor; Cell Survival; Cytokines; Enzyme Inhibit | 2006 |
Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
Topics: Carbazoles; Cell Differentiation; Cell Line, Tumor; Humans; Indoles; K562 Cells; Leukemia, Myeloid; | 2007 |